THURSDAY, Sept. 11, 2024 -- Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab (Leqembi) and donanemab (Kisunla), have been...
Vous n'êtes pas connecté
The UK's medicines regulator has approved a drug that's been shown to slow the progression of Alzheimer's disease, but the government likely won't pay for it.
THURSDAY, Sept. 11, 2024 -- Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab (Leqembi) and donanemab (Kisunla), have been...
A recent study from the University of Bristol has uncovered a promising new method to slow the progression of diabetic kidney disease, a condition...
A new study published in the journal Brain reveals that increasing levels of a key brain protein might help slow cognitive decline in Alzheimer’s...
THE European Medicines Agency (EMA) has ruled out banning or bringing in tougher restrictions on controversial painkiller Nolotil – for now. The...
THE European Medicines Agency (EMA) has ruled out banning or bringing in tougher restrictions on controversial painkiller Nolotil – for now. The...
MICHÈLE SAUNDERS CLAVERY, president of the Alzheimer's Association of TT, says from the increased number of phone calls, e-mails and messages from...
A new report has revealed for the first time the wide-ranging and increasing health dangers posed by long-term weather extremes in the UK, as the...
Mpox is not COVID-19, but that pandemic’s bitter lessons have not all been learnt. By Peter Fabricius An ominous sense of déjà vu is...
Donald Trump's insistence on attaching a voter identification law onto a House funding bill is putting speaker Mike Johnson – and the Republican...
Donald Trump's insistence on attaching a voter identification law onto a House funding bill is putting speaker Mike Johnson – and the Republican...